DL-Tartaric acid
DL-Tartaric acid is a non-racemic enantiomeric mixture exhibiting antioxidant properties. It has been shown to ameliorate non-alcoholic fatty liver disease (NAFLD) in experimental models by activating the AMPK signaling pathway, making it a useful compound for metabolic disease research in both in vitro and in vivo studies.
Product Specifications
CAS Number
133-37-9
Product Name Alternative
DL Tartaric acid, DLTartaric acid, DL-Tartaric acid
Field of Research
Pharmacology & Drug Discovery
Purity
99.61% (May vary between batches)
Solubility
DMSO:80 mg/mL (533.01 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (21.99 mM)
Smiles
[C@H] ([C@@H] (C (O) =O) O) (C (O) =O) O
Molecular Formula
C4H6O6
Molecular Weight
150.09
Storage Conditions
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Notes
For research use only.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human SSBP2 shRNA (UAS) - Lentiviral human SSBP2 shRNA (UAS, GFP) plasmid
RAP1GAP (Rap1 GTPase-activating Protein 1, RAPGAP, RAP1GA1, RAP1GAP1, RAP1GAPII) (MaxLight 490)
RAP1GAP (Rap1 GTPase-activating Protein 1, RAPGAP, RAP1GA1, RAP1GAP1, RAP1GAPII) (MaxLight 490)
